The regulatory review could shape an emerging market that lets companies and investors trade and hedge the cost of increasingly scarce AI computing power.
CME targets an October launch for AI compute futures, subject to CFTC public comment. The new contract would expand CME's derivatives lineup into AI infrastructure costs, adding a revenue stream. Approval is not final; CFTC review introduces uncertainty.
- ▲ CFTC public input process on AI compute futures
- ▲ CME targets October launch
- ▼ CFTC declines to approve contract terms
- ▼ Regulatory delay pushes launch beyond October
▼ Show FAQ (3) ▲ Hide FAQ
What does CFTC review mean for CME stock?
Regulatory approval uncertainty could weigh near term, but a successful launch adds a new revenue stream tied to AI infrastructure demand.
When might CME launch the futures?
CME targets an October launch, pending the outcome of the CFTC public input process.
How does AI compute futures affect CME's product portfolio?
It expands CME beyond traditional commodity and financial futures into a new asset class linked to computing power, diversifying its listing revenue.